Abstract:OBJECTIVE To investigate the effects of human telomerase reverse transcriptase (hTERT) promoter and survivin promoter in tumor-specific gene therapy. METHODS hTERT promoter and survivin promoter were obtained by PCR using Jurkat genomic DNA. Recombinant adeno-associated virus (AAV) vectors containing exogenous TRAIL gene and hTERT promoter or survivin promoter were constructed and designated as rAAV-hTERT-TRAIL (h/TRAIL) or rAAV-survivin-TRAIL (s/TRAIL). rAAV particles were obtained after packing and purification and the virus titer was calculated by real-time PCR. Human hepatocellular carcinoma (HCC) cells of the lines SMMC-7721, BEL-7402, HepG2, and Hep3B, and primary human hepatocytes (PHHs) were transfected with h/TRAIL or s/TRAIL. Flow cytometry was used to detect the expression of the reporter gene enhanced green fluorescent protein (EGFP), so as to examine the activity of the two promoters. MTT method was used to detect the activity of the cells. Fifteen BalB/C mice underwent subcutaneous injection of SMMC-7721 cells so as to establish tumor models and then were randomly divided into 3 groups to undergo intra-tumor injection of h/TRAIL, s/TRAIL, or PBS. The growth of tumor was observed for 5 weeks, and then peripheral blood samples were collected to examine the serum AST and ALT levels. TUNEL was used to detect the apoptosis if the tumor cells. RESULTS All the SMMC-7721, BEL-7402, HepG2, and Hep3B cells driven by both h/TRAIL and s/TRAIL showed EGFP expression, however, no fluorescence could be seen in the PHHs transfected with h/TRAIL and s/ TRAIL. MTT method showed that 72 hours after the transfection of h/TRAIL and s/TRAIL the survival rates of the SMMC-7721, BEL-7402, and HepG2 cells all decreased, however, the survival rate of the Hep3B cells and PHHs did not changed significantly. The size of the subcutaneous tumor of the mice of the h/ TRAIL group was 625 mm3, significantly smaller than that of the PBS group (1500 mm3, P <0.05), however, the tumor size of the s/TRAIL group was 1117 mm3, not significantly different from that of the PBS group (P >0.05). The AST and ALT levels of all mice did not change significantly 5 weeks after the intratumor injection. CONCLUSION Tumor-specific promoters are promising candidates in targeted tumor gene therapy.

Telomerase Reverse Transcriptase Interference Synergistically Promotes Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Oral Squamous Cell Carcinoma Apoptosis And Suppresses Proliferation In Vitro And In Vivo

Anti-liver Cancer Activity of TNF-related Apoptosis-Inducing Ligand Gene and Its Bystander Effects.

Experimental Therapy Against Ovarian Cancer by Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Gene Driven by Human Telomerase Reverse Transcriptase (htert) Promoter

Antisense Oligonucleotides and All-Trans Retinoic Acid Have a Synergistic Anti-Tumor Effect on Oral Squamous Cell Carcinoma

Rna Interference-Mediated Htert Inhibition Enhances Trail-Induced Apoptosis in Resistant Hepatocellular Carcinoma Cells

Synergistic Down-Regulation of Telomerase by All-Trans Retinoic Acid and Antisense Oligonucleotide in Oral Squamous Cell Carcinoma Cell Line (Tca8113)

[Effects of Human Telomerase Reverse Transcriptase Promoter and Survivin Promoter in Targeted Tumor Gene Therapy].

[Synergistic Effects and Mechanisms of Combined Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand and Chemotherapeutic Drugs or Radiotherapy in Killing Laryngeal Squamous Carcinoma Cells in Vitro].

The therapeutic potential of survivin promoter-driven siRNA on suppressing tumor growth and enhancing radiosensitivity of human cervical carcinoma cells via downregulating hTERT gene expression.

Potent Antitumor Effect of Trail Mediated by A Novel Adeno-Associated Viral Vector Targeting to Telomerase Activity for Human Hepatocellular Carcinoma

Blockade of Telomerase Reverse Transcriptase Enhances Chemosensitivity in Head and Neck Cancers Through Inhibition of AKT/ ERK Signaling Pathways

The efficacy of combination therapy using adeno-associated virus-TRAIL targeting to telomerase activity and cisplatin in a mice model of hepatocellular carcinoma

Knockdown Of Htert By Sirna Inhibits Cervical Cancer Cell Growth In Vitro And In Vivo

Antitumor Effects of Targeting Htert Lentivirus-Mediated RNA Interference Against KB Cell Lines

Delivering Antisense Telomerase RNA by a Hybrid Adenovirus/ Adeno-Associated Virus Significantly Suppresses the Malignant Phenotype and Enhances Cell Apoptosis of Human Breast Cancer Cells

Telomerase Reverse Transcriptase Potentially Promotes the Progression of Oral Squamous Cell Carcinoma Through Induction of Epithelial-Mesenchymal Transition.

Telomerase Reverse Transcriptase Mediates EMT Through NF-κB Signaling in Tongue Squamous Cell Carcinoma

RNAi targeting of hTERT gene expression induces apoptosis and inhibits the proliferation of lung cancer cells.

Inhibitory effect of hTERT promoter regulated tumor targeting TRALL combined with chemo-radiotherapy on cervical cancer in vivo

[Inhibition of Telomerase Activity and Induction of Apoptosis in Lung Cancer Cell by Human Telomerase Reverse Transcriptase Gene Antisense Oligodeoxynucleotide].

The antitumor effect and mechanism of antisense oligonucleotide against hTR with all-trans retinoic acid on oral squamous cell carcinoma